vs
Side-by-side financial comparison of MICROVISION, INC. (MVIS) and NORTECH SYSTEMS INC (NSYS). Click either name above to swap in a different company.
NORTECH SYSTEMS INC is the larger business by last-quarter revenue ($30.3M vs $223.0K, roughly 135.9× MICROVISION, INC.). NORTECH SYSTEMS INC runs the higher net margin — 3.0% vs -16930.9%, a 16933.9% gap on every dollar of revenue. On growth, NORTECH SYSTEMS INC posted the faster year-over-year revenue change (5.9% vs -86.5%). NORTECH SYSTEMS INC produced more free cash flow last quarter ($5.5M vs $-15.6M). Over the past eight quarters, NORTECH SYSTEMS INC's revenue compounded faster (-5.9% CAGR vs -51.7%).
MicroVision Inc. is a technology company specializing in advanced LiDAR sensors, miniature display solutions, and perception software. Its core products serve automotive ADAS, augmented reality devices, consumer electronics, and industrial automation markets, delivering high-precision, low-power sensing technologies for next-generation smart applications.
Nortech Systems Inc is a global electronics manufacturing services provider. It delivers end-to-end solutions covering product design, prototyping, full-scale production, and supply chain management for clients operating in medical technology, industrial automation, aerospace and defense, and transportation sectors. It specializes in high-reliability, regulatory-compliant electronic components and assemblies tailored to strict industry standards.
MVIS vs NSYS — Head-to-Head
Income Statement — Q4 2025 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $223.0K | $30.3M |
| Net Profit | $-37.8M | $897.0K |
| Gross Margin | -7220.6% | 16.7% |
| Operating Margin | -18570.0% | 3.0% |
| Net Margin | -16930.9% | 3.0% |
| Revenue YoY | -86.5% | 5.9% |
| Net Profit YoY | -21.2% | 160.7% |
| EPS (diluted) | $-0.12 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $223.0K | $30.3M | ||
| Q3 25 | $241.0K | $30.5M | ||
| Q2 25 | $155.0K | $30.7M | ||
| Q1 25 | $589.0K | $26.9M | ||
| Q4 24 | $1.6M | $28.6M | ||
| Q3 24 | $190.0K | $31.4M | ||
| Q2 24 | $1.9M | $33.9M | ||
| Q1 24 | $956.0K | $34.2M |
| Q4 25 | $-37.8M | $897.0K | ||
| Q3 25 | $-14.2M | $-146.0K | ||
| Q2 25 | $-14.2M | $313.0K | ||
| Q1 25 | $-28.8M | $-1.3M | ||
| Q4 24 | $-31.2M | $-1.5M | ||
| Q3 24 | $-15.5M | $-739.0K | ||
| Q2 24 | $-23.9M | $157.0K | ||
| Q1 24 | $-26.3M | $765.0K |
| Q4 25 | -7220.6% | 16.7% | ||
| Q3 25 | -297.1% | 16.5% | ||
| Q2 25 | -361.9% | 15.8% | ||
| Q1 25 | 6.6% | 11.4% | ||
| Q4 24 | -149.5% | 9.9% | ||
| Q3 24 | -206.8% | 12.2% | ||
| Q2 24 | 18.2% | 13.6% | ||
| Q1 24 | -33.6% | 15.9% |
| Q4 25 | -18570.0% | 3.0% | ||
| Q3 25 | -5278.4% | 3.1% | ||
| Q2 25 | -9455.5% | 2.4% | ||
| Q1 25 | -2383.7% | -6.0% | ||
| Q4 24 | -1119.5% | -4.3% | ||
| Q3 24 | -8266.3% | -1.5% | ||
| Q2 24 | -1296.4% | 1.0% | ||
| Q1 24 | -2793.9% | 3.4% |
| Q4 25 | -16930.9% | 3.0% | ||
| Q3 25 | -5899.2% | -0.5% | ||
| Q2 25 | -9180.0% | 1.0% | ||
| Q1 25 | -4886.1% | -4.9% | ||
| Q4 24 | -1888.2% | -5.2% | ||
| Q3 24 | -8166.8% | -2.4% | ||
| Q2 24 | -1259.5% | 0.5% | ||
| Q1 24 | -2752.4% | 2.2% |
| Q4 25 | $-0.12 | $0.32 | ||
| Q3 25 | $-0.05 | $-0.05 | ||
| Q2 25 | $-0.06 | $0.12 | ||
| Q1 25 | $-0.12 | $-0.48 | ||
| Q4 24 | $-0.15 | $-0.51 | ||
| Q3 24 | $-0.07 | $-0.27 | ||
| Q2 24 | $-0.11 | $0.05 | ||
| Q1 24 | $-0.13 | $0.26 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $74.9M | $1.7M |
| Total DebtLower is stronger | $19.2M | — |
| Stockholders' EquityBook value | $55.5M | $34.5M |
| Total Assets | $103.1M | $71.9M |
| Debt / EquityLower = less leverage | 0.35× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.9M | $1.7M | ||
| Q3 25 | $99.5M | $1.3M | ||
| Q2 25 | $91.4M | $652.0K | ||
| Q1 25 | $69.0M | $1.2M | ||
| Q4 24 | $74.7M | $916.0K | ||
| Q3 24 | $43.2M | $1.2M | ||
| Q2 24 | $56.6M | $1.5M | ||
| Q1 24 | $73.1M | $4.0M |
| Q4 25 | $19.2M | — | ||
| Q3 25 | $29.0M | — | ||
| Q2 25 | $32.3M | — | ||
| Q1 25 | $30.1M | — | ||
| Q4 24 | $33.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $55.5M | $34.5M | ||
| Q3 25 | $90.7M | $33.4M | ||
| Q2 25 | $77.1M | $33.4M | ||
| Q1 25 | $53.2M | $32.8M | ||
| Q4 24 | $48.8M | $34.0M | ||
| Q3 24 | $65.9M | $35.7M | ||
| Q2 24 | $78.7M | $36.1M | ||
| Q1 24 | $93.8M | $36.0M |
| Q4 25 | $103.1M | $71.9M | ||
| Q3 25 | $150.8M | $74.8M | ||
| Q2 25 | $140.6M | $74.8M | ||
| Q1 25 | $116.7M | $73.5M | ||
| Q4 24 | $121.2M | $72.4M | ||
| Q3 24 | $88.3M | $77.0M | ||
| Q2 24 | $103.4M | $76.3M | ||
| Q1 24 | $124.2M | $75.5M |
| Q4 25 | 0.35× | — | ||
| Q3 25 | 0.32× | — | ||
| Q2 25 | 0.42× | — | ||
| Q1 25 | 0.57× | — | ||
| Q4 24 | 0.68× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-15.4M | $5.6M |
| Free Cash FlowOCF − Capex | $-15.6M | $5.5M |
| FCF MarginFCF / Revenue | -7017.5% | 18.0% |
| Capex IntensityCapex / Revenue | 109.4% | 0.5% |
| Cash ConversionOCF / Net Profit | — | 6.25× |
| TTM Free Cash FlowTrailing 4 quarters | $-59.4M | $2.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-15.4M | $5.6M | ||
| Q3 25 | $-16.5M | $-92.0K | ||
| Q2 25 | $-12.7M | $157.0K | ||
| Q1 25 | $-14.1M | $-2.9M | ||
| Q4 24 | $-15.1M | $793.0K | ||
| Q3 24 | $-14.1M | $-1.6M | ||
| Q2 24 | $-18.6M | $-4.3M | ||
| Q1 24 | $-20.8M | $2.8M |
| Q4 25 | $-15.6M | $5.5M | ||
| Q3 25 | $-16.6M | $-242.0K | ||
| Q2 25 | $-12.9M | $58.0K | ||
| Q1 25 | $-14.2M | $-3.2M | ||
| Q4 24 | $-15.2M | $503.0K | ||
| Q3 24 | $-14.1M | $-1.6M | ||
| Q2 24 | $-18.8M | $-4.6M | ||
| Q1 24 | $-20.9M | $2.1M |
| Q4 25 | -7017.5% | 18.0% | ||
| Q3 25 | -6894.6% | -0.8% | ||
| Q2 25 | -8346.5% | 0.2% | ||
| Q1 25 | -2410.4% | -11.9% | ||
| Q4 24 | -918.7% | 1.8% | ||
| Q3 24 | -7421.1% | -5.2% | ||
| Q2 24 | -989.5% | -13.5% | ||
| Q1 24 | -2183.4% | 6.1% |
| Q4 25 | 109.4% | 0.5% | ||
| Q3 25 | 53.1% | 0.5% | ||
| Q2 25 | 134.2% | 0.3% | ||
| Q1 25 | 16.8% | 1.0% | ||
| Q4 24 | 6.2% | 1.0% | ||
| Q3 24 | 4.7% | 0.1% | ||
| Q2 24 | 8.7% | 0.8% | ||
| Q1 24 | 11.9% | 2.2% |
| Q4 25 | — | 6.25× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.50× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -27.30× | ||
| Q1 24 | — | 3.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MVIS
Segment breakdown not available.
NSYS
| Medical Imaging | $11.4M | 37% |
| Medical Device | $8.0M | 26% |
| Industrial | $7.3M | 24% |
| Aerospace And Defense | $3.7M | 12% |
